Anderson IM, Richell RA, Bradshaw CM (2003). The effect of acute
tryptophan depletion on probabilistic choice. J Psychopharmacol
17: 3–7.
Andrews TM, Anderson IM (1998). Information processing in
anxiety: a pilot study of the effect of manipulating 5-HT
function. J Psychopharmacol 12: 155–160.
Aron AR, Fletcher PC, Bullmore ET, Sahakian BJ, Robbins TW
(2003). Stop signal inhibition disrupted by damage to right
inferior frontal gyrus in humans. Nat Neurosc 6: 115–116.
Attenburrow MJ, Mitter PR, Whale R, Terao T, Cowen PJ (2001).
Low-dose citalopram as a 5-HT neuroendocrine probe. Psychopharmacology 155: 323–326.
Attenburrow MJ, Williams C, Odontiadis J, Reed A, Powell J,
Cowen PJ et al (2003). Acute administration of nutritionally
sourced tryptophan increases fear recognition. Psychopharmacology 169: 104–107.
Bechara A, Damasio AR, Damasio H, Anderson SW (1994).
Insensitivity to future consequences following damage to human
prefrontal cortex. Cognition 50: 7–15.
Bel N, Artigas F (1992). Fluvoxamine preferentially increases
extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo
microdialysis study. Eur J Pharmacol 229: 101–103.
Bell CJ, Nutt DJ (1998). Serotonin and panic. Br J Psychiatry 172:
465–471.
Blair RJ, Morris JS, Frith CD, Perrett DI, Dolan RJ (1999).
Dissociable neural responses to facial expressions of sadness and
anger. Brain 122: 883–893.
Casey BJ, Castellanos FX, Giedd JN, Marsh WL, Hamburger SD,
Schubert AB et al (1997). Implication of right frontostriatal
circuitry in response inhibition and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36: 374–383.
Coccaro EF, Kavoussi RJ, Hauger RL (1995). Physiological
responses to d-fenfluramine and ipsapirone challenge correlate
with indices of aggression in males with personality disorder. Int
Clin Psychopharmacol 10: 177–179.
Darwin C (1872). The Expression of Emotions in Man and Animals.
Philosophical Library: New York.
David DJ, Bourin M, Jego G, Przybylski C, Jolliet P, Gardier AM
(2003). Effects of acute treatment with paroxetine, citalopram
and venlafaxine in vivo on noradrenaline and serotonin
outflow: a microdialysis study in Swiss mice. Br J Pharmacol
140: 1128–1136.
Deakin JF (2003). Depression and antisocial personality disorder:
two contrasting disorders of 5HT function. J Neural Transm
64(Suppl): 79–93.
Deakin JFW, Graeff FG (1991). 5-HT and mechanisms of defence.
J Psychopharmacol 5: 305–315.
Dinn WM, Harris CL (2000). Neurocognitive function in antisocial
personality disorder. Psychiatry Res 97: 173–190.
Dolan M, Anderson IM, Deakin JF (2001). Relationship between
5-HT function and impulsivity and aggression in male offenders
with personality disorders. Br J Psychiatry 178: 352–359.
Dolan M, Park I (2002). The neuropsychology of antisocial
personality disorder. Psychol Med 32: 417–427.
Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ et al
(1999). PET imaging of serotonin 1A receptor binding in
depression. Biol Psychiatry 46: 1375–1387.
Ekman P, Friesen WV (1976). Pictures of Facial Affect. Consulting
Psychologists: Palo Alto.
Elliott R, Dolan RJ, Frith CD (2000a). Dissociable functions in the
medial and lateral orbitofrontal cortex: evidence from human
neuroimaging studies. Cereb Cortex 10: 308–317.
Elliott R, Friston KJ, Dolan RJ (2000b). Dissociable neural
responses in human reward systems. J Neurosci 20: 6159–6165.
Elliott R, Newman JL, Longe OA, Deakin JF (2003). Differential
response patterns in the striatum and orbitofrontal cortex to
financial reward in humans: a parametric functional magnetic
resonance imaging study. J Neurosci 23: 303–307.
